BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 32060274)

  • 1. Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma.
    Kalaora S; Lee JS; Barnea E; Levy R; Greenberg P; Alon M; Yagel G; Bar Eli G; Oren R; Peri A; Patkar S; Bitton L; Rosenberg SA; Lotem M; Levin Y; Admon A; Ruppin E; Samuels Y
    Nat Commun; 2020 Feb; 11(1):896. PubMed ID: 32060274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the immunoproteasome protects SH-SY5Y cells from the toxicity of rotenone.
    Sun C; Mo M; Wang Y; Yu W; Song C; Wang X; Chen S; Liu Y
    Neurotoxicology; 2019 Jul; 73():112-119. PubMed ID: 30904435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A MAGE-C2 antigenic peptide processed by the immunoproteasome is recognized by cytolytic T cells isolated from a melanoma patient after successful immunotherapy.
    Ma W; Vigneron N; Chapiro J; Stroobant V; Germeau C; Boon T; Coulie PG; Van den Eynde BJ
    Int J Cancer; 2011 Nov; 129(10):2427-34. PubMed ID: 21207413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoproteasome down-modulation enhances the ability of dendritic cells to stimulate antitumor immunity.
    Dannull J; Lesher DT; Holzknecht R; Qi W; Hanna G; Seigler H; Tyler DS; Pruitt SK
    Blood; 2007 Dec; 110(13):4341-50. PubMed ID: 17855630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The LMP7-K allele of the immunoproteasome exhibits reduced transcript stability and predicts high risk of colon cancer.
    Fellerhoff B; Gu S; Laumbacher B; Nerlich AG; Weiss EH; Glas J; Kopp R; Johnson JP; Wank R
    Cancer Res; 2011 Dec; 71(23):7145-54. PubMed ID: 22037870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-alpha mediates the up-regulation of HLA class I on melanoma cells without switching proteasome to immunoproteasome.
    Cangemi G; Morandi B; D'Agostino A; Peri C; Conte R; Damonte G; Ferlazzo G; Biassoni R; Melioli G
    Int Immunol; 2003 Dec; 15(12):1415-21. PubMed ID: 14645150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering the tumor-suppressive role of PSMB9 in melanoma through multi-omics and single-cell transcriptome analyses.
    Hu X; Hu Z; Zhang H; Zhang N; Feng H; Jia X; Zhang C; Cheng Q
    Cancer Lett; 2024 Jan; 581():216466. PubMed ID: 37944578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple structural and epigenetic defects in the human leukocyte antigen class I antigen presentation pathway in a recurrent metastatic melanoma following immunotherapy.
    Chang CC; Pirozzi G; Wen SH; Chung IH; Chiu BL; Errico S; Luongo M; Lombardi ML; Ferrone S
    J Biol Chem; 2015 Oct; 290(44):26562-75. PubMed ID: 26381407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequency of functionally active Melan-a-specific T cells in a patient with progressive immunoproteasome-deficient melanoma.
    Meidenbauer N; Zippelius A; Pittet MJ; Laumer M; Vogl S; Heymann J; Rehli M; Seliger B; Schwarz S; Le Gal FA; Dietrich PY; Andreesen R; Romero P; Mackensen A
    Cancer Res; 2004 Sep; 64(17):6319-26. PubMed ID: 15342421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of immunoproteasome function in the lung.
    Keller IE; Vosyka O; Takenaka S; Kloß A; Dahlmann B; Willems LI; Verdoes M; Overkleeft HS; Marcos E; Adnot S; Hauck SM; Ruppert C; Günther A; Herold S; Ohno S; Adler H; Eickelberg O; Meiners S
    Sci Rep; 2015 May; 5():10230. PubMed ID: 25989070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoproteasome subunits LMP2 and LMP7 downregulation in primary malignant melanoma lesions: association with lack of spontaneous regression.
    Dissemond J; Goette P; Moers J; Lindeke A; Goos M; Ferrone S; Wagner SN
    Melanoma Res; 2003 Aug; 13(4):371-7. PubMed ID: 12883363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the processing of seven human tumor antigens by intermediate proteasomes.
    Guillaume B; Stroobant V; Bousquet-Dubouch MP; Colau D; Chapiro J; Parmentier N; Dalet A; Van den Eynde BJ
    J Immunol; 2012 Oct; 189(7):3538-47. PubMed ID: 22925930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of immunoproteasome PSMB8 is associated with Parkinson's disease.
    Nguyen HD; Kim YE; Nhat Nguyen LT; Kwak IH; Lee YK; Kim YJ; Hai Nguyen TT; Pham HN; Ma HI
    Parkinsonism Relat Disord; 2023 Sep; 114():105797. PubMed ID: 37562243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative haplotypes of antigen processing genes in zebrafish diverged early in vertebrate evolution.
    McConnell SC; Hernandez KM; Wcisel DJ; Kettleborough RN; Stemple DL; Yoder JA; Andrade J; de Jong JL
    Proc Natl Acad Sci U S A; 2016 Aug; 113(34):E5014-23. PubMed ID: 27493218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal IFN-gamma-dependent immunoproteasome modulation by Trypanosoma cruzi-infected macrophages.
    Bergeron M; Blanchette J; Rouleau P; Olivier M
    Parasite Immunol; 2008 May; 30(5):280-92. PubMed ID: 18312504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of immunoproteasome subunits in myositis indicates active inflammation with involvement of antigen presenting cells, CD8 T-cells and IFNΓ.
    Ghannam K; Martinez-Gamboa L; Spengler L; Krause S; Smiljanovic B; Bonin M; Bhattarai S; Grützkau A; Burmester GR; Häupl T; Feist E
    PLoS One; 2014; 9(8):e104048. PubMed ID: 25098831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Analysis of Proteasome Subunits and Transporter Associated with Antigen Processing on Chinese Patients with Parkinson's Disease.
    Mo MS; Huang W; Sun CC; Zhang LM; Cen L; Xiao YS; Li GF; Yang XL; Qu SG; Xu PY
    Chin Med J (Engl); 2016 May; 129(9):1053-8. PubMed ID: 27098790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association and expression of the antigen-processing gene PSMB8, coding for low-molecular-mass protease 7, with vitiligo in North India: case-control study.
    Dani P; Patnaik N; Singh A; Jaiswal A; Agrawal B; Kumar AA; Varkhande SR; Sharma A; Vaish U; Ghosh P; Sharma VK; Sharma P; Verma G; Kar HK; Gupta S; Natarajan VT; Gokhale RS; Rani R
    Br J Dermatol; 2018 Feb; 178(2):482-491. PubMed ID: 28207947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IP-score correlated to endogenous tumour antigen peptide processing: A candidate clinical response score algorithm of immune checkpoint inhibitors therapy in multiple cohorts.
    Wang Y; Yan K; Guo Y; Lu Y; Su H; Li H
    Front Immunol; 2022; 13():1085491. PubMed ID: 36700205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells.
    Morel S; Lévy F; Burlet-Schiltz O; Brasseur F; Probst-Kepper M; Peitrequin AL; Monsarrat B; Van Velthoven R; Cerottini JC; Boon T; Gairin JE; Van den Eynde BJ
    Immunity; 2000 Jan; 12(1):107-17. PubMed ID: 10661410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.